Acerta Pharma
Pre-clinicalAcerta Pharma is a leader in the field of covalent binding technology who is applying this technology to create novel, highly selective therapies for cancer.
Founded
2012
Focus
Small Molecules
About
Acerta Pharma is a leader in the field of covalent binding technology who is applying this technology to create novel, highly selective therapies for cancer.
Funding History
1Total raised: $350M
Series A$350MAstraZenecaJan 15, 2015
Company Info
TypePrivate
Founded2012
LocationOss, Netherlands
StagePre-clinical
Contact
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile